Hanmi Pharm shares jump 30% on Genentech obesity drug deal
Hanmi Pharm shares jump 30% on Genentech obesity drug deal
Auto Added by WPeMatico
Hanmi Pharm shares jump 30% on Genentech obesity drug deal
“We expect real yields to continue rising until they choke off the borrowing which has been driving them – and the rotation into risk which has been fuelling the equity rally,” he wrote in a note. Ashok Bhatia, chief investment officer at Neuberger, said US real yields remained below the 3 to 4 percent range where he expects…
HM17321, a proprietary UCN2 (urocortin-2) analog, is being developed as a treatment for chronic-weight management and associated conditions, including obesity Total deal value of up to $2.3 billion, including upfront, milestone payments and tiered royalties based on net sales SEOUL, South Korea, Aug. 24, 2026 /PRNewswire/ — Hanmi Pharm announced today that it has entered…
Report once: will Esma’s €1bn reforms deliver the full picture? – Risk.net Skip to main content Close navigation menu End of drawer navigation content Critics say plan to merge three reporting regimes will see scant returns, and won’t mesh with single-sided reporting The bigger picture or the better picture first? It’s a question for the…
Plenty of people are drawn to places like Florida for their retirement, looking for warmer weather and a more laid-back lifestyle. For those who lean more towards an outdoorsy life — and that don’t mind a cold winter — Colorado has become a top choice. Full of natural beauty, outdoor adventures and a vibrant culture,…
Typically, when a finance team loses good people, it is almost certain that someone offered them more money. That story is getting harder to tell nowadays. Processing Content The Controllers Council’s 2026 talent study found the market flipped from a surplus to a 77% shortage in a single year, with controllers named the hardest role…
This article is republished with permission from Wonder Tools, a newsletter that helps you discover the most useful sites and apps. I always fuss over how best to add visual variety. I do that so you, dear reader, aren’t bored by thick walls of text. (I halved the length of this post for the same reason)….
Private equity firms have reportedly begun placing artificial intelligence experts within their portfolio companies to grow those businesses. That’s according to a report Friday (Aug. 21) from The Wall Street Journal (WSJ), which cites the example of Wall Street firms like Blackstone and Hellman & Friedman’s $1.5 billion partnership with Anthropic to form an approximately…
By Saikat Das and Bhaskar Dutta Citigroup Inc. has tied up with Axis Bank Ltd. to finance non-resident Indians investing in foreign-currency deposits with the local lender, according to people familiar with the matter. Axis Bank will provide standby letters of credit to support financing extended by Citigroup through its…
Data3 shares surge to record high on strong AI-fueled earnings